Ibuprofen Zentiva 800 mg Filmdragerad tablett

Land: Sverige

Språk: svenska

Källa: Läkemedelsverket (Medical Products Agency)

Ladda ner Produktens egenskaper (SPC)
05-08-2021

Aktiva substanser:

ibuprofen

Tillgänglig från:

Zentiva k.s.

ATC-kod:

M01AE01

INN (International namn):

ibuprofen

Dos:

800 mg

Läkemedelsform:

Filmdragerad tablett

Sammansättning:

ibuprofen 800 mg Aktiv substans

Receptbelagda typ:

Receptbelagt

Produktsammanfattning:

Förpacknings: Blister, 10 tabletter; Blister, 100 tabletter; Blister, 20 tabletter; Blister, 30 tabletter

Bemyndigande status:

Godkänd

Tillstånd datum:

2021-05-04

Produktens egenskaper

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Ibuprofen Zentiva 400 mg film-coated tablets
Ibuprofen Zentiva 600 mg film-coated tablets
Ibuprofen Zentiva 800 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each  400 mg film-coated tablet contains ibuprofen 400
mg.
Each  600 mg film-coated tablet contains ibuprofen 600
mg.
Each  800 mg film-coated tablet contains ibuprofen 800
mg.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet
 400 mg film-coated tablet: white to off-white rounded
film-coated tablets with
diameter 12 mm.
 600 mg film-coated tablet: white to off-white oblong
(17 x 10 mm) film-coated
tablets.
 800 mg film-coated tablet: light yellow to beige oblong
(20 x 10 mm) film-coated
tablets.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
[ 400 mg, 600 mg and 800 mg film-coated tablets]
Rheumatic conditions such as arthritic diseases (e.g. rheumatoid
arthritis including juvenile
rheumatoid arthritis), non-articular rheumatic conditions, other
muscular and joint disorders, and soft
tissue injuries.
 400 mg and 600 mg is recommended for adults and
adolescents from 40 kg
bodyweight (over 12 years).
800 mg  is recommended for adults only (see section
4.2).
[400 mg film-coated tablets]
In addition,  400 mg is intended for short-term
symptomatic treatment of mild to
moderate pain, migraine, primary dysmenorrhea and/or fever.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The treatment should start with the lowest dose anticipated to be
effective, which can subsequently be
adjusted, depending on the therapeutic response and any undesirable
effects.
The maximum single dose should not exceed 800 mg of ibuprofen for
adults and 600 mg of ibuprofen
for adolescents.
Undesirable effects may be minimised by using the lowest effective
dose for the shortest duration
necessary to con
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel engelska 05-04-2023
Produktens egenskaper Produktens egenskaper engelska 05-04-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport engelska 25-03-2021

Sök varningar relaterade till denna produkt